Click on a filter below to refine your search. Remove a filter to broaden your search.
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
The first novel therapy for Alzheimer’s disease in almost two decades was approved today by the Food & Drug Administration.